Delivery Order SPE2DE24D0013-SPE2D626F111Q
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, was awarded a delivery order valued at $5,236.00 by the Defense Logistics Agency Medical Supply Chain on October 27, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is for diagnostic testing supplies supporting detection of COVID-19, influenza, and respiratory syncytial virus, with a firm fixed-price structure and ultimate completion date of November 10, 2025. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $3,740 on October 26, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The contract, designated as XPCOV2/FLU/RSV-10, is structured as a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and carries no set-aside designation. This delivery order represents a continuation of Cepheid's extensive federal...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic systems, was awarded a $68,000 firm fixed-price delivery order (Contract No. 4569923609, XPCOV2/FLU/RSV-10) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, which carries no set-aside designation, is for diagnostic reagents and test kits related to COVID-19, influenza, and respiratory syncytial virus (RSV)...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $17,162.40 by the Defense Logistics Agency Medical Supply Chain on October 20, 2025. This delivery order, designated XPRSMVP-10, is set to be completed by October 27, 2025, and represents an order for molecular diagnostic reagents and test kits designed for the GeneXpert diagnostic platform. The work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $5,440 firm fixed-price delivery order (4569923610) by the Defense Logistics Agency Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus—consistent with Cepheid's core competency in rapid molecular diagnostic testing...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $8,603.68 by the Defense Logistics Agency Medical Supply Chain on October 23, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, calls for diagnostic reagents and test kits for the GeneXpert platform, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Work will be performed in Sunnyvale, California,...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order (XPRSMVP-10) valued at $2,304.20 under a Defense Logistics Agency Medical Supply Chain Indefinite Delivery Contract. This firm fixed-price delivery order, issued on November 12, 2025, with an ultimate completion date of November 19, 2025, involves the supply of molecular diagnostic products, consistent with Cepheid's core business of providing advanced diagnostic solutions. The contract carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F111QDelivery Order
Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,099.70 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, represents procurement of diagnostic reagents and test kits—specifically XPRS4PLEX-10 cartridges designed for the GeneXpert diagnostic platform. The contract utilizes no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of molecular diagnostic solutions. Performance will occur at Cepheid's Sunnyvale facility. This delivery order is representative of Cepheid's extensive federal contracting relationships across multiple defense and civilian healthcare agencies. The company serves as a core supplier to the Department of Veterans Affairs through two significant Indefinite Delivery Contracts—including a $32.8 million IDC with VISN 6 extending through September 30, 2030—and maintains active contracts with the Defense Health Agency, Indian Health Service, and U.S. Coast Guard for diagnostic equipment, reagents, maintenance services, and point-of-care testing capabilities. Cepheid's GeneXpert platform and associated molecular testing systems provide rapid detection of infectious diseases including COVID-19, influenza, respiratory syncytial virus, and drug-resistant tuberculosis, supporting clinical laboratory operations across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 11/12/25 |